Road to 2025: Clinical trials hit fever pitch for Island Pharmaceuticals

Stockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes they’re plotting towards a successful year ahead.

In this episode, Fraser Palamara investigates Island Pharmaceuticals (ASX:ILA) and its antiviral drug development making strides against dengue fever.

This video was developed in collaboration with Island Pharmaceuticals, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.